Another look at the age-old question: Which came first, the elevated c-reactive protein or the atherothrombosis?*

Cardiosource
Marc S. Sabatine, Eugene Braunwald
Thus, in the early management of patients with ACS, it may not be sufficient simply to lower the level of low-density lipoprotein cholesterol, as all three statins did in these trials; the goal also must be to reduce inflammation, as reflected by lowering CRP.